| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/08/2006 | WO2006060246A2 Apparatus and system having dry control gene silencing compositions |
| 06/08/2006 | WO2006060140A2 Monoclonal anti-idiotypic antibody as a probe to define the viral receptor and as a vaccine candidate for porcine reproductive and respiratory syndrome virus |
| 06/08/2006 | WO2006060125A2 Compositions and methods for using radio frequency identifiers in biological sciences |
| 06/08/2006 | WO2006059952A1 Diagnosis of tamoxifen sensitivity |
| 06/08/2006 | WO2006059911A1 Method of sample analysis and apparatus therefor |
| 06/08/2006 | WO2006059769A1 Method of diagnosing malignant lymphoma and estimating the prognosis thereof |
| 06/08/2006 | WO2006059717A1 Method of analyte organism identification, internal standard dna composition for use in this method and process for producing the same |
| 06/08/2006 | WO2006059691A1 Method of screening antiobesity drug |
| 06/08/2006 | WO2006059408A1 Lactic acid bacterium binding to human abo blood types |
| 06/08/2006 | WO2006059386A1 Method of isolating double-stranded dna containing simple sequence repeats |
| 06/08/2006 | WO2006059359A1 Measuring kit for microbe in liquid sample, and relevant measuring method and measuring apparatus |
| 06/08/2006 | WO2006059125A2 Tumour suppressor genes |
| 06/08/2006 | WO2006059121A2 Modulators of spindle checkpoint kinases and a taxol |
| 06/08/2006 | WO2006059111A2 Fungal signalling and metabolic enzymes |
| 06/08/2006 | WO2006059075A1 A method for increasing the specificity of enzymatic dna synthesis |
| 06/08/2006 | WO2006058936A1 Method of detecting antibiotic residues and other antimicrobial compounds |
| 06/08/2006 | WO2006058900A1 The lupac bifunctional marker and its use in protein production |
| 06/08/2006 | WO2006058779A1 Diffusion and enzyme layer for an enzyme-based sensor application |
| 06/08/2006 | WO2006058427A1 Platelet-derived growth factor-responsive neural precursor cells and progeny thereof |
| 06/08/2006 | WO2006058425A1 Sparc promoter mutations associated with drug resistance, and methods, oligonucleotides, cells and arrays associated therewith |
| 06/08/2006 | WO2006058395A2 Tools and methods for the quantification of dna repeats |
| 06/08/2006 | WO2006058393A1 Methods for simplifying microbial nucleic acids by chemical modification of cytosines |
| 06/08/2006 | WO2006058375A1 Identification of compounds for the treatment of proliferative disorders |
| 06/08/2006 | WO2006039537A3 A system and method for inhibiting the decryption of a nucleic acid probe sequence used for the detection of a specific nucleic acid |
| 06/08/2006 | WO2006037994A3 Egfr mutations altering the response to erbb receptor drugs |
| 06/08/2006 | WO2006031936A3 Device and method for detecting antibiotic-inactivating enzymes |
| 06/08/2006 | WO2006026738A3 Methods and compositions for rna amplification and detection using an rna-dependent rna-polymerase |
| 06/08/2006 | WO2006025801A3 Methods for cancer diagnosis |
| 06/08/2006 | WO2006024541A3 Dna decontamination method |
| 06/08/2006 | WO2006021558A3 A plant with reduced lignin by modulating dahps gene expression |
| 06/08/2006 | WO2006020302A3 Biomarkers for bladder cancer |
| 06/08/2006 | WO2006018425A3 Multiphase biocompatible semi-permeable membrane for biosensors |
| 06/08/2006 | WO2006013474A3 PPGALNAC-t6 MRNA or peptide as a new marker for detection cancer cells |
| 06/08/2006 | WO2006007472A3 Non-invasive glucose measurement |
| 06/08/2006 | WO2005123963A3 Methods and compositions for use in analyte detection using proximity probes |
| 06/08/2006 | WO2005121419A3 Rapid and efficient cdna library screening by self-ligation of inverse pcr products |
| 06/08/2006 | WO2005118868A3 Screening for compounds that affect the pathophysiologic mechanisms of neurological disorders |
| 06/08/2006 | WO2005098039A3 Method and apparatus for analyzing and generating human antibody amino acid and nucleic acid sequences |
| 06/08/2006 | WO2005097818A3 An assay system for screening protease inhibitors |
| 06/08/2006 | WO2005093036A3 Inhibitors of siderophore biosynthesis in fungi |
| 06/08/2006 | WO2005092069A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 06/08/2006 | WO2005091971A3 Compositions for use in identification of alphaviruses |
| 06/08/2006 | WO2005089414A3 Neoplasia diagnostic compositions and methods of use |
| 06/08/2006 | WO2005085423A8 Oct-4 and gjic expression as markers for adult human stem cells and cancer cell precursors |
| 06/08/2006 | WO2005076893A3 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 06/08/2006 | WO2005074599A3 Naphthalimide dosing by n-acetyl transferase genotyping |
| 06/08/2006 | WO2005069900A3 Npc1l1 (npc3) and methods of identifying ligands thereof |
| 06/08/2006 | WO2005059161A3 Methods for evaluation a bacteriophage preparation |
| 06/08/2006 | WO2005056753A3 Methods of determining juvenile arthritis classification |
| 06/08/2006 | WO2005053601A3 Methods of generating stem cells and embryonic bodies carrying disease-causing mutations and methods of using same for studying genetic disorders |
| 06/08/2006 | WO2005035724A3 Cancer-linked genes as targets for chemotherapy |
| 06/08/2006 | WO2005028629A3 Whole genome expression analysis system |
| 06/08/2006 | WO2005002527A3 Sirt1 modulation of adipogenesis and adipose function |
| 06/08/2006 | WO2004109449A3 Analysis of data from a mass spectrometer |
| 06/08/2006 | WO2004087866A3 Methods for the identification of inhibitors of lipid transfer protein activity in plants |
| 06/08/2006 | WO2003089904A3 Aib1 as a prognostic marker and predictor of resistance to encocrine therapy |
| 06/08/2006 | WO2003086292A3 Use of na,k-atpase a-and b-subunits in bladder cancer detection and drug screening |
| 06/08/2006 | WO2003076571A3 Cancer-linked gene as target for chemotherapy |
| 06/08/2006 | US20060123505 Full-length plant cDNA and uses thereof |
| 06/08/2006 | US20060123498 Paks as modifiers of the chk pathway and methods of use |
| 06/08/2006 | US20060123497 Sperm-specific cation channel, catsper-4, and uses therefor |
| 06/08/2006 | US20060123495 Knockout mice and their use |
| 06/08/2006 | US20060123491 Method for a (high through-put) screening detection of genetic modifications in genome engineering |
| 06/08/2006 | US20060122816 Computer systems and methods for subdividing a complex disease into component diseases |
| 06/08/2006 | US20060122789 Symmetry relationships between pairs of connectrons |
| 06/08/2006 | US20060122788 Method of identifying changes in biopolymers |
| 06/08/2006 | US20060122372 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 06/08/2006 | US20060122137 5'-methylpyrimidine and 2'-O-methyl ribonucleotide modified double-stranded ribonucleic acid molecules |
| 06/08/2006 | US20060122136 Effective and stable DNA enzymes |
| 06/08/2006 | US20060122135 Cloning and expression of a novel member of the Glial cell-line derived neurotrophic factors (GDNF); Parkinson's , Alzheimer's , Huntington's, Creutzfeld-Jacob diseases, neuropathic pain; acute brain injury, multiple sclerosis, amyotrophic lateral sclerosis, peripheral nerve trauma; cancer |
| 06/08/2006 | US20060122134 double-stranded decoy oligonucleotide; atherosclerosis; acts as a competitive inhibitor (or rather neutralisation) of a natural core-binding sequence of a DNA-binding protein or protein complex thereby blocks the expression of the eNOS |
| 06/08/2006 | US20060122132 Use of murine genomic regions identified to be involved in tumor developement for the development of anti-cancer drugs and diagnosis of cancer |
| 06/08/2006 | US20060121610 Transferring particles through cell barriers; insert cell into electrically conductive fluid, monitor electrical current, adjust voltage to maintain preferential diffusion |
| 06/08/2006 | US20060121604 Methods and materials for expression of a recombinant protein |
| 06/08/2006 | US20060121602 Optical scanning configurations, systems, and methods |
| 06/08/2006 | US20060121580 Binding molecules against SARS-coronavirus and uses thereof |
| 06/08/2006 | US20060121579 Regulated nucleic acid expression system |
| 06/08/2006 | US20060121567 Infectious bursal disease virus (IBDV) variant from Georgia |
| 06/08/2006 | US20060121564 Novel expression vector suitable for expression of recombinant protein at low temperature |
| 06/08/2006 | US20060121555 Bio-enrichment device to enhance sample collection and detection |
| 06/08/2006 | US20060121554 Regulation of human RTA-like GPCR |
| 06/08/2006 | US20060121553 Fluorogenic enzyme assay methods, kits and compositions using charge-balancers |
| 06/08/2006 | US20060121552 Reporter protein fused to at least one protease cleavage sequence, and a linker for attaching the protease cleavage sequence to a solid support, can be used to quantitate protease activity, as well as be used to identify the type of protease being assayed |
| 06/08/2006 | US20060121551 Novel phenoxazinone derivatives as enzyme substrates and use thereof as indicator in the detection of microorganisms with peptidase activity |
| 06/08/2006 | US20060121550 Modulation of PDE11A activity |
| 06/08/2006 | US20060121549 Methods and devices for detecting pancreatic lipase |
| 06/08/2006 | US20060121548 Systems and methods for measuring sodium concentration in saliva |
| 06/08/2006 | US20060121547 Diffusion layer for an enzyme-based sensor application |
| 06/08/2006 | US20060121546 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |
| 06/08/2006 | US20060121537 Cellular immunity test with peptides fixed on a solid support |
| 06/08/2006 | US20060121535 Polyacrylamide-based methods of fabricating surface-bound peptide and protein arrays; detecting surface-immobilized biomolecules |
| 06/08/2006 | US20060121532 Glycated insulin as a biomarker for diagnosis and monitoring of diabetes |
| 06/08/2006 | US20060121529 CpG receptor (CpG-R) and methods relating thereto |
| 06/08/2006 | US20060121528 Recombinant Candida rugosa lipases |
| 06/08/2006 | US20060121527 Oncoprotein protein kinase |
| 06/08/2006 | US20060121526 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
| 06/08/2006 | US20060121525 Methods and compositions for producing linearly amplified amounts of (+) strand RNA |
| 06/08/2006 | US20060121524 Oligonucleotide primers of SEQ ID NOs. 1 to 21 and a process for detection of a parasite Salmonella using oligonucleotide primers |
| 06/08/2006 | US20060121523 Transporter genes OATP-B, C, D, and E |
| 06/08/2006 | US20060121522 Stimulating an immune response in human or animal, by administering a gene which LACKS A FUNCTIONAL VHS GENE, lacks a functional gene encoding ICP47, COMPRISES A FUNCTIONAL UL43 GENE, to infect DENDRITIC CELLS; increase gene expression on the surface of tumour cells; protection against cancer; vaccines |